The American Heart Association and the American Diabetes Association are excited to announce a new podcast series for healthcare professionals. Know Diabetes by Heart™ Professional Education Podcast Series focuses on the link between cardiovascular disease (CVD) and type 2 diabetes (T2D). The series…
American Heart Association and American Diabetes Association
Listen to Walter N. Kernan, MD, Heather Ferris, MD, PhD, and Alejandro A. Rabinstein, MD discuss preventing strokes in type 2 diabetes, risk factors for stroke, treatment and management options for stroke prevention, and the importance of multidisciplinary team care.
Listen to Katherine R. Tuttle, MD, FASN, FACP, FNKF, Anthony Good, DNP, MBA, FNP-BC, GNP-BC, and Joshua J. Neumiller, PharmD, CDCES, FASCP, FADCES discuss the prevalence of heart failure, chronic kidney disease, type 2 diabetes, and the impact these conditions have on patient outcomes. Management options to mitigate these risks, current guidelines and diagnostic practices will also be discussed.
Listen to Rodica Busui (Pop-Busui), MD, PhD, Neha J. Pagidipati, MD, MPH, and Jennifer B. Green, MD discuss ASCVD (atherosclerotic cardiovascular disease) progression in patients with type 2 diabetes, strategies to assess its risk, and the COORDINATE study.
Listen to Michael J. Blaha, MD, MPH and Richard E. Pratley, MD discuss the link between type 2 diabetes and chronic kidney disease (CKD) as well as taking a multidisciplinary approach to managing people with type 2 diabetes at risk for chronic kidney disease progression.
Listen to Traci Thompson, MD, MBA, CPE, Latha Palaniappan, MD, MS, and Alka Kanaya, MD discuss racial and ethnic considerations when screening and managing patients with type 2 diabetes (T2D) and cardiovascular disease (CVD), as well as related health care disparities and barriers in managing and treating T2D and CVD.
This podcast highlights the new science presented at the American Heart Association's (AHA's) Scientific Sessions in 2022. Jane Reusch, MD, Nathan Wong, PhD, MPH, and Chiadi Ndumele, MD, PhD, MHS discuss clinical highlights related to CVD risk management in patients with diabetes, including renal disease, and how to incorporate these findings into clinical practice.
Help patients with diabetes manage their risk for heart disease and stroke. Donald Lloyd-Jones, MD, ScM, FAHA, FACC and Jane EB Reusch, MD, FAHA discuss the recent release of AHA's Life's Essential 8 which was expanded from Life's Simple 7 to include healthy sleep for optimal cardiovascular health as well as other lifestyle factors included in Life's Essential 8 and how health care professionals can use this checklist to help patients with diabetes manage their risk for heart disease and stroke.
Diabetes is more than a blood sugar problem. Help your patients with type 2 diabetes understand their risk of cardiovascular disease and the importance of blood pressure, lipid, and glucose control in managing risk. Listen to Nathan Wong, PhD, MPH and Colette Knight, MD discuss ways for patients to know and understand their numbers in LDL cholesterol, triglycerides, blood pressure, A1C, and more.
Listen to Eduardo Sanchez, MD, MPH, FAHA and Robert A. Gabbay, MD, PhD give an update on the initiative from launch through 2021 including notable insights, key learnings and future outlook as well as empowering patients to be active members of their health care team.
Listen to Philip P. Goodney, MD, MS, Foluso A. Fakorede, MD and Peter A. Schneider, MD discuss the differences in preventive measures offered to patients with diabetes and peripheral artery disease (PAD) as well as better delivery of preventive measures to high-risk patients and high-risk regions in the United States.
Listen to Dr. Jennifer Green and Dr. Neha Pagidipati discuss the utilization of SGLT2i and GLP-1RA in the hospital setting in patients with indications for such therapy, as described in the 2021 ADA Standards of Medical Care and current AHA guidelines, including the recent ASA/AHA Recurrent Stroke prevention guidelines.
Listen to George L. Bakris, MD, FAHA, FASN, Cecilia C. Low Wang, MD, FACP and Neda Rasouli, MD educate clinicians on the updates made in the 2021 ADA Standards of Care related to metformin use and considerations for when the guideline recommends considering use of SGLT-2 Inhibitors and GLP-1 receptor agonists independent of A1C or metformin use.
Listen to Dr. Boris Draznin, an endocrinologist and specialist in diabetes and internal medicine, and Dr. Pam Kushner, a specialist in family medicine discuss how the new American Diabetes Association’s 2021 Standards of Care have changed and implications for practice.
Patients with T2D and CKD have a very high risk of CV events. Listen as Dr. Jorge Plutzky and Dr. Neha Pagidipati discuss new therapies to manage cardiovascular and renal risk in patients with T2D. Their discussion is based on new science presented during AHA Scientific Sessions 2020.
Listen as Dr. Eduardo Sanchez from the American Heart Association and Dr. Robert Gabbay from the American Diabetes Association discuss social determinants of health and disparities in health and health care in individuals with type 2 diabetes at risk for cardiovascular disease and COVID-19 and what can be done to improve their outcomes.
Listen to leading experts discuss the new Scientific Statement from the American Heart Association, “Cardiorenal Protection With the Newer Antidiabetic Agents in Patients With Diabetes and Chronic Kidney Disease,” where two newer groups of medications prescribed primarily for Type 2 diabetes treatment (SGLT2 inhibitors and GLP-1 receptor agonists) could significantly reduce risks associated with chronic kidney disease (CKD) and heart disease.
Listen to Dr. Jay Shubrook, DO, a primary care physician and Dr. Bankim Bhatt, MD, an adult endocrinologist discuss diabetes management, telemedicine, and lessons learned in the time of COVID-19.
Listen to members of the writing group for the new AHA statement on the clinical management of stable coronary artery disease in patients with T2D. Dr. Suzanne Arnold, Chair, and fellow writing group members, Dr. Prakash Deedwania and Dr. Mikhail Kosiborod will review highlights from the statement, including recent clinical trials which uncovered several new drugs that not only reduce glucose, but also improve cardiovascular and renal outcomes.
People with type 2 diabetes and chronic kidney disease are at three times higher risk of dying from a cardiovascular event. According to the National Kidney Foundation, the two main causes of chronic kidney disease are diabetes and high blood pressure. These two conditions were the primary diagnosis in 75% of kidney failure cases between 2015-2017. Listen to Dr. George Bakris, a nephrologist with expertise in diabetes-related kidney disease, and Dr. Peter McCullough, a cardiologist who is also board certified in internal medicine, discuss how to better screen and manage patients with type 2 diabetes who are at risk for cardiovascular disease and renal disease.
Listen to Dr. Nancy Albert, a clinical nurse specialist and lead researcher in heart failure and Dr. Mikhail Kosiborod, a cardiologist and expert in the fields of diabetes, cardiovascular diseases, cardiometabolic and cardiorenal syndromes, and quality care and outcomes discuss heart failure management in patients with type 2 diabetes and cardiovascular disease.
Studies on COVID-19 are revealing that patients diagnosed with COVID-19 and who have type 2 diabetes and history of cardiovascular disease are showing increased complications. Listen to Dr. Anne Peters, an endocrinology, diabetes and metabolism specialist and Dr. Diana Issacs, an endocrine clinical pharmacy specialist discuss tackling COVID-19 in their practices, including telehealth tips on getting started, treatment plan considerations, and ways to help patients prepare.
Listen to Dr. Jorge Plutzky, a cardiologist, and Dr. Joshua Joseph, an endocrinologist, discuss with patients the challenges and barriers they face living with T2D and CVD, and how health care providers can best support them.
Listen to Dr. Jennifer Green, an endocrinologist and diabetes and metabolism specialist and Dr. David Aguilar, a cardiologist and board certified in internal medicine, discuss how the new American Diabetes Association’s 2020 Standards of Care have changed and implications for practice.
Goal setting and discussing lifestyle management with your patients is critical in managing the link between diabetes and heart disease. Listen to Dr. Nathanial Clark, an endocrinologist, and Melissa Magwire, a nurse and CDE (Certified Diabetes Educator) discuss how to initiate the conversation and set your patient up for success.
In a recent survey of people age 45 and older with type 2 diabetes, conducted online by The Harris Poll, only half recognize their cardiovascular risk or have discussed their risk of heart attacks or strokes with their health care providers. Listen to cardiologist, Dr. Tracy Wang and endocrinologist, Dr. Robert Eckel discuss how a cardiologist can play a pivotal role in helping his/her patients with type 2 diabetes better manage their cardiovascular disease risk.
The management of type 2 diabetes to prevent cardiovascular disease has been focused on glycemic control and the use of drugs based on their ability to lower levels of glycemia. Listen to Dr. Robert Eckel and Dr. Chris Cannon discuss the use of anti-hyperglycemic agents with CVD benefits.
Diabetes education has positive effects not only on psychosocial and behavioral aspects of diabetes care, but also known to be a cost-effective treatment by reducing hospital readmissions and lowered risk for complications. Yet, many patients often do not receive DSMES (Diabetes Self-Management Education and Support) referrals. Listen to Nancy D’Hondt, a certified diabetes educator and registered pharmacist, Dr. Lillian Khor, a cardiologist and Dr. Jay Shubrook, an osteopathic family physician, discuss how they work with CDEs and the benefits found from referring patients to diabetes self-management programs and a certified diabetes educator.
Identifying and implementing optimal treatment strategies for patients living with diabetes and heart failure is critical to improving outcomes for this population. Shannon Dunlay, MD, MS discusses managing patients with diabetes who are at risk for heart failure or those that have heart failure. This podcast is based on the new scientific statement from the American Heart Association and the Heart Failure Society of America. * *Type 2 Diabetes Mellitus and Heart Failure
The ASCVD Risk Calculator is a tool that enables healthcare providers and patients to estimate 10-year risk for atherosclerotic cardiovascular disease or ASCVD. Salim Virani, MD discusses the ASCVD risk calculator and why this assessment needs to be performed in patients with diabetes.
Shared decision-making is an effective approach to ensure patient and family involvement in decision-making and tailoring of treatment plans to meet goals. Jay Shubrook, DO, Robert Eckel, MD, and Patricia Montesinos, CRNP, CDE discuss how to interview and bring their patients to a collaborative discussion and joint treatment plan.
For people with diabetes, blood glucose isn’t the only important factor to track. New guidelines suggest the more than 110 million U.S. adults with diabetes or prediabetes should also manage their cholesterol as well as their blood glucose. Drs. Ronald Goldberg and Robert Eckel discuss the new American Heart Association’s 2018 Cholesterol Guidelines, released in November 2018, and the implications for type 2 diabetes along with pharmacotherapy and lifestyle interventions.
Christopher Cannon, MD and Ronald Goldberg, MD discuss the management and treatment of diabetes to prevent cardiovascular disease in the new American Diabetes Association’s 2019 Standards of Care.
Eduardo Sanchez, MD and William Cefalu, MD discuss the link between CVD and T2D